ARTICLE | Company News
Management tracks: Celgene, Seres, AC Immune
October 23, 2018 8:48 PM UTC
Celgene Corp. (NASDAQ:CELG) hired Alise Reicin as president of global clinical development, a newly created position. She was SVP and head of global clinical development in R&D at the EMD Serono business of Merck KGaA (Xetra:MRK).
Seres Therapeutics Inc. (NASDAQ:MCRB) hired Kevin Horgan as EVP and CMO. He succeeds CMO Michele Trucksis, who will become a consultant for the microbiome company. Horgan was VP of clinical development at AstraZeneca plc (LSE:AZN; NYSE:AZN)...